- bulk
Supplier Type
- Reagent
- Manufacturer
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Mumbai(80)
- Hyderabad(45)
- Telangana(6)
- Andhra Pradesh(5)
- Tamil Nadu(2)
- Karnataka(8)
- Bangalore(2)
- Vadodara(11)
- Ahmedabad(13)
- Maharashtra(43)
- Madhya Pradesh(3)
- Delhi(11)
- New Delhi(7)
- Pune(9)
- Gujarat(40)
- Beijing(4)
- Haryana(4)
- Punjab(1)
- Uttar Pradesh(3)
- Kerela(1)
- Ujjain(1)
- Kolkata(1)
Purity
- Rasagiline Mesylate Impurity C
- Purity By Gc Nlt 98%
- NMR
- NLT 98%
- NLT 90.00%
- N/A
- min 99%
- Greater than 99%
- good
- Dipropargyl r- amino indane
- API Impurity / in-house working standard
- 99.99%
- 99.99
- 99.97%
- 99.91%
- 99.90%
- 99.9%
- >99.9%
- 99.9 %
- 99.89%
- 99.86%
- 99.84%
- 99.80 %
- 99.79%
- 99.72%
- 99.6
- 99.59%
- 99.56%
- 99.54%
- 99.51%
- 99.50%
- 99.5%+
- 99.5%
- 99.5 %
- 99.47%
- 99.41%
- 99.40%
- 99.35%
- 99.34%
- 99.33%
- 99.32%
- 99.26%
- 99.21%
- 99.20%
- 99.18%
- 99.17%
- 99.04%
- 99.00%
- 99.0%
- 99%,HPLC
- 99% Minimum
- 99% Min
- 99% HPLC
- 99% for GC
- 99% and above
- 99% ABOVE
- >99%
- 99%
- 99 %
- 99
- 98+
- 98.97%
- 98.67%
- 98.62%
- 98.57%
- 98.30%
- 98.22%
- 98.10%
- 98.03%
- 98.00%
- 98.0%
- 98.0 %
- 98%+
- 98% min
- 98% +
- 98%
- >98%
- 98 %
- 98
- 97-99%
- 97.51%
- 97.25%
- 97.00%
- 97.0%min,97%min
- 97.0%
- >97%
- 97%
- 97 to 98
- 97 %
- 96.56%
- 96.00%
- 96% - 98%
- 96%
- 95-99%
- 95-98%
- 95.81%
- 95.00%
- 95% & 97%
- 95%
- >95%
- 94.00%
- 92.64%
- >92%
- 90.00%
- 90%
- 90 % Above
- 84.76%
- 82.70%
- 76.82%
- 65%
- 600
- 20% /25%/ 1.2M/1.4M
- 2.0M
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 100%
- 1.8M
- 1.0M/3.0M
- 1.0M/2.0M
- 1.0M
- 0.7M in
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 500mg
- 1gm
- 5g
- 50g
- 100gm
- 100ml
- 500ml
- 1L
- 100
- 1g
- 10g
- 25g
- 200
- 100g
- 25
- 50
- 0MG TO GRAM
- 250mg
- 500gm
- 500g
- 1kg
- 1000g
- 5kg
- 10kg
- 25kg
- 40kg
- 50kg
- 100kg
- 500kg
- 1000kg
- 1and gm
- 1MT
- 1KG WITH NITROGEN PURGING
- 250kgs
- 250250 mg.
- 255025kg in 50litre HDPE drum
-
1,1'-Carbonyldiimidazole
530-62-1
-
(S)-2-((Methoxycarbonyl)aMino)-3-Methylbutanoic acid
74761-42-5
-
1-(1,4-Benzodioxane-2-carbonyl)piperazine
70918-00-2
-
N-BOC-piperidine-4-carboxylic acid
84358-13-4
-
N-[(S)-(+)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine
82717-96-2
-
(S)-benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate
70637-26-2
-
Carbamic acid, N-[3-[(methylamino)carbonyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
2604515-02-6
-
Dabigatran etexilate
211915-06-9
-
Cbz-Valaciclovir
124832-31-1
-
N-[(1,1-dimethylethoxy)carbonyl]-,(4S)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3',4',6,7]indolizino[1,2-b]quinolin-4-yl ester
362496-99-9
N,N-Dimethylformamide 68-12-2
N,N-Diethylethanolamine 100-37-8
N,N-Diethylhydroxylamine 3710-84-7
Methyl n-nonyl acetaldehyde 110-41-8
3-Chloro-N,N-dimethylpropylamine hydrochloride 5407-04-5
Niacinamide-N-oxide 1986-81-8
N,N-Dimethylformamide 68-12-2
(1R,4R)-rel-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-Naphthalenamine hydrochloride (1:1) 79617-89-3
N-(4-chlorophenyl)-2,2 dimethylpropanamide 65854-91-3
N,N-Dimethylformamide 68-12-2